Titlebook: Hepatobiliary Cancers: An Interdisciplinary Approach; Nima Rezaei Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusi

Malleable

安定

mosque

Liver Cancer and the Curative Potential of Nanomedicine,the diagnosis occurs frequently at a late stage, where treatment options are limited. Immunotherapy based on targeting checkpoint inhibitors, which unleashes the break of antitumor immunity, works only for a minority of patients. This might partly be owed to the tolerogenic function of the liver. Na

bioavailability

SPER

Drug Resistance in Hepatocellular Carcinoma,e acquired drug resistance increasingly affects the management of HCC patients. Researchers have focused on drug resistance for many years and identified complex regulatory networks involved in this issue. In this chapter, the significant research progress regarding mechanisms underlying HCC drug re

Inelasticity

Liver Stereotactic Body Radiotherapy (SBRT),organs. In addition, these patients have had worse tumor outcomes when new immunotherapies have been tested in clinical trials, together suggesting there is something especially immunosuppressive about the liver tissue. Initial preclinical and translational studies have brought some light into this

Malfunction

搏斗

BUST

recede

Liver Cancer: Interdisciplinary Approach,nvolving multiple signaling pathways such as VEGFR, EGFR, Raf/MEK/ERK, PI3K/AKT, and Wnt. Chronic hepatitis B virus infection is the most common cause. Combining the high-risk factors, imaging features and serological molecular markers of liver cancer, biopsy or surgical resection of liver space-occ